GGrantIndex
Sort

85,873 grants matching alzheimers

Non-coding RNAs in resilience to Alzheimer’s Disease

$844,278
Frank J. Slack · Beth Israel Deaconess Medical Center · R01 · FY2024 · AG

INTERDISCIPLINARY APPROACH TO ALZHEIMER DRUG DISCOVERY

$844,145
Nathan S. Kline Institute For Psych Res · P01 · FY2001 · AG

Unraveling the intersection of synaptic biology, lifestyle, and cognitive resilience

$844,139
Kaitlin B Casaletto · University Of California, San Francisco · R01 · FY2025 · AG

Integrated understanding of complex viral network biology in Alzheimer's Disease

$844,112
Joel Thomas Dudley · Icahn School Of Medicine At Mount Sinai · R56 · FY2017 · AG

Proteomic characterization of exosomes from AD patients

$844,015
John Robert Yates · Scripps Research Institute, The · R56 · FY2017 · AG

Autoimmune features of neurodegenerative disorders

$844,007
David Sulzer · Columbia University Health Sciences · R01 · FY2019 · NS

Harmonizing multi-site diffusion MRI acquisitions for neuroscientific analysis across ages and brain disorders

$843,974
Yogesh Rathi · Brigham And Women'S Hospital · R01 · FY2019 · MH

PRO: A Protein Ontology in OBO Foundry for Integration of Biomedical Knowledge

$843,962
Cathy H Wu · University Of Delaware · R01 · FY2013 · GM

Antisocial Behavior in Frontotemporal Dementia: Behavioral Phenotypes, Neural Markers, and Decision-Making Mechanisms

$843,959
Richard Ryan Darby · Vanderbilt University Medical Center · R01 · FY2024 · AG

Testing miR-132 signaling and replacement as a common strategy for AD, FTD, and related pathologies

$843,850
Anna M. Krichevsky · Brigham And Women'S Hospital · R56 · FY2020 · AG

Administrative Core

$843,845
Thomas J Montine · University Of Washington · P50 · FY2017 · AG

Harnessing Knowledge of Gene Function in Brain Tissue for Discovering Biology Underlying Heroin Addiction

$843,825
Eric O Johnson · Research Triangle Institute · R01 · FY2017 · DA

Development of novel lipid nanoparticles for nucleic acids delivery in the brain

$843,806
Yizhou Dong · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · EB

Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes

$843,756
Godfrey D Pearlson · Yale University · R01 · FY2007 · MH

Neural and Biochemical Mechanisms of Cognitive Aging

$843,745
William J. Jagust · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2019 · AG

Linking Sleep Disruption to Tau Accumulation and Network Dysregulation in Early Alzheimer's Disease

$843,700
Jasmeer P Chhatwal · Massachusetts General Hospital · R01 · FY2024 · AG

Determining the neuroprotective mechanism for microglial autophagy in Alzheimer's disease

$843,612
Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG

Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease

$843,557
Stephen R Salton · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AG

Goals of Care Addressing Disparities and Variation for Alzheimer's Disease Nursing Home Care at End of Life

$843,404
Laura C Hanson · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AG

A deep learning algorithm to detect signs of cognitive impairment in electronic health records

$843,365
Sudeshna Das · Massachusetts General Hospital · R56 · FY2023 · AG

Using geroscience to understand and treat Alzheimer's disease

$843,328
Pamela Anne Maher · Salk Institute For Biological Studies · R01 · FY2020 · AG

Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease

$843,281
Madeleine Eve Hackney · Emory University · R01 · FY2022 · AG

Digital Neurodegenerative Pathology After Repetitive Head Impacts

$843,248
Jesse Benjamin Mez · Boston University Medical Campus · R01 · FY2025 · NS

Tau progression index (TPI): An individualized predictor of Alzheimer's Disease trajectory based on subject-specific connectomes

$843,163
Qolamreza Ray Razlighi · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AG

Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's Disease

$843,061
Shusuke Toden · Superfluid Dx, Inc. · R44 · FY2024 · AG